Association and heterogeneity at the GAPDH locus in Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 1, 2012, Pages 203.e25-203.e33

  Allen, Mariet ^a,b   Cox, Claire ^a   Belbin, Olivia ^a   Ma, Li ^a   Bisceglio, Gina D ^a   Wilcox, Samantha L ^a   Howell, Chanley C ^a   Hunter, Talisha A ^a   Culley, Oliver ^a   Walker, Louise P ^a   Carrasquillo, Minerva M ^a   Dickson, Dennis W ^a   Petersen, Ronald C ^c   Graff Radford, Neill R ^a   Younkin, Steven G ^a   Ertekin Taner, Nilüfer ^a  

^a MAYO CLINIC   (United States)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Association studies in genetics; Case control studies

Indexed keywords

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GAPDH GENE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LATE ONSET ALZHEIMER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 81355139583     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.08.002     Document Type: Article

References (21)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
2. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet 2007, 39:17-23.
3. Carrasquillo M.M., Zou F., Pankratz V.S., Wilcox S.L., Ma L., Walker L.P., Younkin S.G., Younkin C.S., Younkin L.H., Bisceglio G.D., Ertekin-Taner N., Crook J.E., Dickson D.W., Petersen R.C., Graff-Radford N.R., Younkin S.G. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat. Genet 2009, 41:192-198.
4. Colell A., Ricci J.E., Tait S., Milasta S., Maurer U., Bouchier-Hayes L., Fitzgerald P., Guio-Carrion A., Waterhouse N.J., Li C.W., Mari B., Barbry P., Newmeyer D.D., Beere H.M., Green D.R. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007, 129:983-997.
5. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7(3):177-188.
6. Ertekin-Taner N. Genetics of Alzheimer's disease: a centennial review. Neurol. Clin 2007, 25:611-667.
7. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
8. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease [Erratum in: 2009;41, 1156]. Nat. Genet 2009, 41:1088-1093.
9. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fievet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet 2009, 41(10):1094-1099.
10. Lee J.H., Cheng R., Rogaeva E., Meng Y., Stern Y., Santana V., Lantigua R., Medrano M., Jimenez-Velazquez I.Z., Farrer L.A., St George-Hyslop P., Mayeux R. Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease. Neurogenetics 2008, 9:127-138.
11. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S., Hinrichs A.L., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Gogic G., Chan J., Cravchik A., Ross D., Lau K., Kwok S., Chang S.Y., Catanese J., Sninsky J., White T.J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Owen M., Williams J., Goate A., Grupe A. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15688-15693.
12. Lin P.I., Martin E.R., Bronson P.G., Browning-Large C., Small G.W., Schmechel D.E., Welsh-Bohmer K.A., Haines J.L., Gilbert J.R., Pericak-Vance M.A. Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease. Neurology 2006, 67:64-68.
13. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet 2007, 80:531-538.
14. Mayeux R., Lee J.H., Romas S.N., Mayo D., Santana V., Williamson J., Ciappa A., Rondon H.Z., Estevez P., Lantigua R., Medrano M., Torres M., Stern Y., Tycko B., Knowles J.A. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am. J. Hum. Genet 2002, 70:237-243.
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
16. Myers A., Wavrant De-Vrieze F., Holmans P., Hamshere M., Crook R., Compton D., Marshall H., Meyer D., Shears S., Booth J., Ramic D., Knowles H., Morris J.C., Williams N., Norton N., Abraham R., Kehoe P., Williams H., Rudrasingham V., Rice F., Giles P., Tunstall N., Jones L., Lovestone S., Williams J., Owen M.J., Hardy J., Goate A. Full genome screen for Alzheimer disease: stage II analysis. Am. J. Med. Genet 2002, 114:235-244.
17. Nakajima H., Amano W., Kubo T., Fukuhara A., Ihara H., Azuma Y.T., Tajima H., Inui T., Sawa A., Takeuchi T. Glyceraldehyde-3-phosphate dehydrogenase aggregate formation participates in oxidative stre ss-induced cell death. J. Biol. Chem 2009, 284:34331-34341.
18. Newton-Cheh C., Hirschhorn J.N. Genetic association studies of complex traits: design and analysis issues. Mutat. Res 2005, 573:54-69.
19. Reiman E.M., Webster J.A., Myers A.J., Hardy J., Dunckley T., Zismann V.L., Joshipura K.D., Pearson J.V., Hu-Lince D., Huentelman M.J., Craig D.W., Coon K.D., Liang W.S., Herbert R.H., Beach T., Rohrer K.C., Zhao A.S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C.B., Ravid R., Rogers J., Hutton M.L., Melquist S., Petersen R.C., Alexander G.E., Caselli R.J., Kukull W., Papassotiropoulos A., Stephan D.A. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007, 54:713-720.
20. Rogaeva E., Premkumar S., Song Y., Sorbi S., Brindle N., Paterson A., Duara R., Levesque G., Yu G., Nishimura M., Ikeda M., O'Toole C., Kawarai T., Jorge R., Vilarino D., Bruni A.C., Farrer L.A., St George-Hyslop P.H. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 1998, 280:614-618.
21. Scott W.K., Grubber J.M., Conneally P.M., Small G.W., Hulette C.M., Rosenberg C.K., Saunders A.M., Roses A.D., Haines J.L., Pericak-Vance M.A. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am. J. Hum. Genet 2000, 66:922-932.